Scanning the Market is your go-to pulse on the rapidly evolving radiology world. It cuts straight to the real conversations shaping the future of healthcare, AI, and innovation. In this episode of Scanning the Marketing, host Jay Gurney chats with Steve Worrell, CEO of Riverain, a company revolutionising radiology through AI and image enhancement. From his early days in military machine learning to becoming a pioneer in CAD for breast imaging, Steve shares the long journey that led him to Riverain. This conversation explores how Riverain has remained profitable by focusing on precision, product quality, and sustainable growth - eschewing the typical VC-backed trajectory of many medtech startups. Steve explains why their AI innovations like vessel suppression stand out, how radiologists are driving product decisions, and why hiring slowly with intention is a non-negotiable. Whether you’re a founder, technologist, or just fascinated by the future of diagnostics, this episode offers hard-earned wisdom on scaling in a complex and high-stakes market. What You’ll Learn: 1. Why Good Tech Alone Isn’t EnoughSteve shares that a high-performing AI tool must also be seamlessly integrated into radiologists’ workflows. Products that feel like an afterthought won’t gain traction, no matter how accurate they are. 2. Staying Lean and Profitable in HealthTechUnlike many peers, Riverain has grown without overextending. Steve discusses the pitfalls of hypergrowth, the risks of overhiring, and the benefits of “killing what you eat.” 3. The Power of Clinical CollaborationRiverain’s roadmap isn’t dictated by engineers alone. Clinical advisory boards help vet ideas early, ensuring tools address real-world needs and deliver ROI for providers. About the Guest: Steve Worrell is the CEO of Riverain Technologies, where he leads a lean, innovation-focused team developing advanced AI tools for radiology. With roots in military research and an early role in breast imaging at ICAD, Steve brings decades of experience at the intersection of machine learning and medical diagnostics. Under his leadership, Riverain has achieved rare profitability while continuing to innovate, with tools like vessel suppression and nodule detection helping radiologists interpret chest scans more efficiently and accurately. Steve believes in playing the long game—building sustainable products that solve real problems for clinicians. 🔗 Links and Resources: Steve Worrell on LinkedInJay Gurney on LinkedInProjectusRiverain Technologies Timestamps: 00:00 – Intro and tech challenges getting started03:00 – Steve’s early AI work and transition from military to healthcare08:00 – Why Steve joined Riverain and what made it appealing14:00 – Hiring smart: the challenge of finding the right people20:00 – Workflow vs diagnostic AI: what actually gets adopted25:00 – Radiologist-first development: the role of bone/vessel suppression32:00 – When to kill a product: lessons from clinical trial results40:00 – The trap of scaling too fast: VC pressures vs market reality48:00 – Running lean: how 34 people doubled ARR year after year54:00 – What’s next for Riverain and why they’re staying focused🔑 Keywords:AI in healthcare, diagnostic imaging, radiology, Riverain, lung nodules, vessel suppression, Steve Worrell, medical startups, scaling a business, clinical workflow, profitable startups, RSNA, deep tech, product-market fit, VC funding, radiologist tools, startup hiring, chest imaging, medtech growth